Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
about
Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.Managing Your Own Mood Lability: Use of Mood Stabilizers and Antipsychotics in Pregnancy.Bipolar Disorder in Pregnancy and Postpartum: Principles of Management.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Prophylactic use of olanzapine and quetiapine from pregnancy to the postpartum period in women with bipolar disorder: a case series.Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: a population-based cohort study in Denmark.Bipolar Disorder in Pregnancy: A Review of Pregnancy Outcomes.Fetal exposure to lamotrigine and quetiapine in two consecutive pregnancies.Characteristics of antipsychotic medication prescribing on inpatient obstetric floors.The Perinatal Treatment Conundrum.Relationship Between Pregnancy Complications and Psychiatric Disorders: A Population-Based Study With a Matched Control Group.[Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].Prevalence of xenobiotic substances in first-trimester blood samples from Danish pregnant women: a cross-sectional study.Haloperidol-Associated Uterine Dystonia.
P2860
Q31056264-1967B7C2-D79D-4727-B2AF-A4DE47D749C4Q36209588-331861E6-8825-4E9D-BEDE-73E760A42FEFQ38674230-9A1C4905-C8C5-479C-9EE1-88C18CACB88BQ38701750-3B601D8F-7D19-4E7F-9538-E151B24849EBQ38811512-ADAFC736-AE1D-4EF0-A67E-FE23679A0FAFQ39220495-248EADAB-0DB0-47B9-92FA-319B075229B6Q47162514-A5BE4438-7432-42BD-A736-0A601EB3AEAEQ47586027-A39B257E-6231-4A0E-9872-D7E6D0F18FCEQ47966330-F32CB34A-232F-426B-A723-76F0FEA48F2CQ48003394-9DD83792-D7BC-4674-B3B2-C189C578DC4BQ49184302-4D3B1316-8BDC-4F17-A0C1-836956B39661Q50019926-48BE6B34-5043-4EE9-BB8B-6606AB2FBCE3Q50490346-09EE68CC-FA4B-4AAE-9F13-4127F1D0FE5AQ50578078-721084F2-44BA-4D97-95A8-DE6CE27F8959Q53652828-46A12DFB-B865-4E68-BF85-3635D22DEFE6
P2860
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@ast
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@en
type
label
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@ast
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@en
prefLabel
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@ast
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@en
P2093
P2860
P1476
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy
@en
P2093
Catherine G Coughlin
Christine Bartley
Katherine A Blackwell
Madeleine Hay
Michael H Bloch
P2860
P304
P356
10.1097/AOG.0000000000000759
P407
P577
2015-05-01T00:00:00Z